Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(38:5e)/PE(38:4p) | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 291 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 640 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 527 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 394 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 338 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 442 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 132 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 187 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | C | 0.0 | BCD100427B001 | 296 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | C | 0.5 | BCD100427B003 | 425 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | C | 1.0 | BCD100427B007 | 819 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | C | 2.0 | BCD100427B011 | 388 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | C | 4.0 | BCD100427B015 | 420 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | C | 8.0 | BCD100427B019 | 261 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | C | 12.0 | BCD100427B023 | 360 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | C | 24.0 | BCD100427B027 | 115 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 395 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 369 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 342 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 335 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 530 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 90.8 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 204 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol | 0.5 | BCD100427B004 | 774 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol | 1.0 | BCD100427B008 | 382 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol | 2.0 | BCD100427B012 | 926 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol | 4.0 | BCD100427B016 | 395 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol | 8.0 | BCD100427B020 | 176 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol | 12.0 | BCD100427B024 | 530 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol | 24.0 | BCD100427B028 | 54.3 | pmol/sample |